Perception and Attitude of Malaysian Community Pharmacists Towards the Implementation of Telepharmacy

Main Article Content

Wei Liang Ng
Wei Thing Sze

Abstract




Introduction: Telepharmacy refers to the delivery of pharmaceutical care service through telecommunication to patients in locations where they may not have direct contact with a pharmacist. During the COVID-19 pandemic, the role of pharmacist has expanded to provide services remotely through telepharmacy. This study aimed to assess Malaysian community pharmacists’ perception and attitude towards implementing telepharmacy. Method: This cross-sectional study was carried out from August 2020 to October 2020 using an online self-administered question- naire. 217 community pharmacists in Klang Valley were recruited through convenience sampling method. 5-point Likert scales were used to evaluate the respondent’s perceived benefits, perceived barriers and attitude towards the implementation of telepharmacy. Results: 37.8% of the respondents showed positive perception while 53.9% are moderately positive towards towards the benefits of telepharmacy. Age (p=0.019) was shown to impact on the perceived benefits on implementation of telepharmacy. Only 8.3% of the community pharmacists perceived low barriers in telepharmacy implementation and it was significantly associated with education level of the respondents (p=0.032). Younger community pharmacists and community pharmacists who have less years of working experience were more likely to have a positive attitude towards the implementation of telepharmacy (p<0.001). Conclusion: In conclusion, most Malaysian community pharmacists practicing in urban area has shown positive perception and attitude towards the benefits and implementation of telepharmacy. However, the perceived barriers towards its implementation is high. A separate training or education on telemedicine may be useful to promote the use of telemedicine to all the pharmacists.




Downloads

Download data is not yet available.

Article Details

How to Cite
Ng, W. L., & Sze, W. T. (2022). Perception and Attitude of Malaysian Community Pharmacists Towards the Implementation of Telepharmacy. Malaysian Journal of Medicine and Health Sciences, 18(5), 72–78. https://doi.org/10.47836/mjmhs18.5.11
Section
Original Articles

References

WHO Group Consultation on Health Telematics 1997: Geneva S. A health telematics policy in support of WHO’s Health-for-all strategy for global health development : report of the WHO Group Consultation on Health Telematics, 11- 16 December, Geneva, 1997. 1998 [cited 2020 Dec 15]; Available from: https://apps.who.int/iris/ handle/10665/63857

Baldoni S, Amenta F, Ricci G. Telepharmacy Services: Present Status and Future Perspectives: A Review. Medicina (Mex) [Internet]. 2019 Jul 1 [cited 2020 Aug 3]; 55(7). doi: 10.3390/ medicina55070327.

Gross AE, MacDougall C. Roles of the clinical pharmacist during the COVID-19 pandemic. JACCP J Am Coll Clin Pharm. 2020; 3(3): 564–6. doi: 10.1002/jac5.1274.

Ameri A, Salmanizadeh F, Bahaadinbeigy K. Tele- pharmacy: A new opportunity for consultation during the COVID-19 pandemic. Health Policy Technol [Internet]. 2020 Jun [cited 2020 Aug 3]; doi: 10.1016/j.hlpt.2020.06.005.

Adunlin G, Murphy PZ, Manis M. COVID-19: How Can Rural Community Pharmacies Respond to the Outbreak? J Rural Health [Internet]. 2020 [cited 2020 Dec 17];n/a(n/a). doi:10.1111/jrh.12439

Rogers H, Madathil KC, Agnisarman S, Narasimha S, Ashok A, Nair A, et al. A Systematic Review of the Implementation Challenges of Telemedicine Systems in Ambulances. Telemed E-Health. 2017 Sep; 23(9): 707–17. doi: 10.1089/tmj.2016.0248.

Kurra P, Babu P. Telepharmacy: A Benefaction For Rural Healthcare Types of Tele Pharmacy. 2019 Mar 14; 60–4.

Kane-Gill SL, Rincon F. Expansion of Telemedicine Services: Telepharmacy, Telestroke, Teledialysis, Tele-Emergency Medicine. Crit Care Clin. 2019 Jul; 35(3): 519–33. doi: 10.1016/j.ccc.2019.02.007

Molfenter T, Boyle M, Holloway D, Zwick J. Trends in telemedicine use in addiction treatment. Addict Sci Clin Pract. 2015 Dec; 10(1): 14. doi: 10.1186/ s13722-015-0035-4.

Green T, Hartley N, Gillespie N. Service Provider’s Experiences of Service Separation: The Case of Telehealth. J Serv Res. 2016 Nov; 19(4): 477–94. doi:10.1177/1094670516666674

Malaysian Pharmaceutical Society [Internet]. [cited 2020 Aug 20]. Available from: https://www.mps. org.my/index.cfm

Ameri A, Salmanizadeh F, Keshvardoost S, Bahaadinbeigy K. Investigating Pharmacists’ Views on Telepharmacy: Prioritizing Key Relationships, Barriers, and Benefits. J Pharm Technol [Internet]. 2020 [cited 2020 Aug 8]; doi:10.1177/8755122520931442

Biruk K, Abetu E. Knowledge and Attitude of Health Professionals toward Telemedicine in Resource-Limited Settings: A Cross-Sectional Study in North West Ethiopia [Internet]. Vol. 2018, Journal of Healthcare Engineering. Hindawi; 2018 [cited 2020 Aug 20]. p. e2389268. doi: 10.1155/2018/2389268.

McFarland R. Telepharmacy for remote hospital inpatients in north-west Queensland. J Telemed Telecare. 2017 Dec; 23(10): 861–5. doi: 10.1177/1357633X17732367.

Niznik JD, He H, Kane-Gill SL. Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: A systematic review. Res Soc Adm Pharm. 2018 Aug; 14(8): 707–17. doi: 10.1016/j.sapharm.2017.10.011.

Lam AY, Rose D. Telepharmacy services in an urban community health clinic system. J Am Pharm Assoc. 2009 Sep; 49(5): 652–9. doi: 10.1331/ JAPhA.2009.08128.

Friesner DL, Scott DM, Rathke AM, Peterson CD, Anderson HC. Do remote community telepharmacies have higher medication error rates than traditional community pharmacies? Evidence from the North Dakota Telepharmacy Project. J Am Pharm Assoc. 2011 Sep; 51(5): 580–90. doi: 10.1331/JAPhA.2011.10115.

Gaggioli A, di Carlo S, Mantovani F, Castelnuovo G, Riva G. A Telemedicine Survey among Milan Doctors. J Telemed Telecare. 2005 Jan; 11(1): 29–34. doi: 10.1177/1357633X0501100107.

Mohammadzadeh N, Safdari R, Rahimi A. Cancer Care Management through a Mobile Phone Health Approach: Key Considerations. Asian Pac J Cancer Prev. 2013 Sep 30; 14(9): 4961–4. doi: 10.7314/ apjcp.2013.14.9.4961.

Omboni S, Tenti M. Telepharmacy for the management of cardiovascular patients in the community. Trends Cardiovasc Med. 2019 Feb; 29(2): 109–17. doi: 10.1016/j.tcm.2018.07.002.

Bali S. Barriers to Development of Telemedicine in Developing Countries. In: F. Heston T, editor. Telehealth [Internet]. IntechOpen; 2019 [cited 2021 Jan 12]. doi:10.5772/intechopen.81723

Albarrak AI, Mohammed R, Almarshoud N, Almujalli L, Aljaeed R, Altuwaijiri S, et al. Assessment of physician’s knowledge, perception and willingness of telemedicine in Riyadh region, Saudi Arabia. J Infect Public Health. 2021 Jan 1; 14(1): 97–102. doi:10.1016/j.jiph.2019.04.006

Fulk J. Social construction of communication technology. Academy of Management Journal 1993;36:921–50. doi:10.5465/256641

Solberg LA, Natvig H, Endestad T, et al. IT Changes in Norwegian Firms: IT Quality and Users’ Mastering of a New Technology. STF 78 A98405. Oslo: SINTEF Unimed,1998